Evaluation of Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Reingold, Jason S.
Nasir, Khurram
Patel, Neel R.
Pourfarzib, Ray
Winegar, Deborah
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2413-PO
引用
收藏
页码：A614 / A615
页数：2
相关论文
共 50 条
  • [41] A Cross-Sectional Evaluation of Cardiovascular Risk Assessment in Type 2 Diabetes Mellitus Patients Using the Framingham Risk Score
    Rathod, Mitali B.
    Moukthika, Shashum
    Karikunnel, Allwyn John
    Harika, Kottala
    Talla, Prathibha
    Jalakam, Madhurika
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [42] Cardiovascular risk assessment and association with novel biomarkers in patients with Type 2 diabetes mellitus
    Neri, Ane K. M.
    Junior, Geraldo B. da S.
    Meneses, Gdayllon C.
    Martins, Alice M. C.
    Daher, Elizabeth De F.
    Lino, Danielli O. da C.
    Silva, Ricardo P.
    Nunes, Marina de P. S. F.
    Alencar, Renan L.
    Rodrigues, Mariane S.
    Saraiva, Igor P.
    BIOMARKERS IN MEDICINE, 2021, 15 (08) : 561 - 576
  • [43] Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
    Verbovoy, A. F.
    Pashentseva, A. V.
    Verbovaya, N. I.
    Madyanov, I. V.
    Sharonova, L. A.
    Galkin, R. A.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (08) : 113 - 117
  • [44] Dyslipidaemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy
    Martínez-Castelao, A
    Ramos, R
    González, MT
    Castiñeiras, MJ
    NEFROLOGIA, 2002, 22 : 51 - 58
  • [45] ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF CARDIOVASCULAR DEATH IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Phung, O. J.
    Sakharkar, P. R.
    Law, A., V
    VALUE IN HEALTH, 2012, 15 (04) : A171 - A171
  • [46] A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus
    Biryukova, E. V.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (10) : 98 - 102
  • [47] Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Zinman, Bernard
    Inzucchi, Silvio E.
    Lachin, John M.
    Wanner, Christoph
    Fitchett, David
    Kohler, Sven
    Mattheus, Michaela
    Biomath, Dipl
    Woerle, Hans J.
    Broedl, Uli C.
    Johansen, Odd Erik
    Albers, Gregory W.
    Diener, Hans Christoph
    STROKE, 2017, 48 (05) : 1218 - +
  • [48] Using Repeated Measurements to Predict Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Gokhale, Krishna M.
    Chandan, Joht Singh
    Sainsbury, Chris
    Tino, Peter
    Tahrani, Abd
    Toulis, Konstantinos
    Nirantharakumar, Krishnarajah
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 210 : 133 - 142
  • [49] The Effect of Thyroid Dysfunction on the Cardiovascular Risk of Type 2 Diabetes Mellitus Patients in Ghana
    Sarfo-Kantanka, Osei
    Sarfo, Fred Stephen
    Ansah, Eunice Oparebea
    Kyei, Ishmael
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [50] Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
    Hertzel C Gerstein
    Salim Yusuf
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 798 - 799
12345